Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
What the clinical data shows From the Phase 2 trial: Two patterns stand out
In a PCPA-induced insomnia mouse model, DSIP-CBBBP outperformed DSIP alonemore effectively restoring neurotransmitter balance, reducing wakefulness, easing anxiety and depression-like behaviors, improving reward response, and repairing brain tissue damage
No customs delays intra-EU shipment
This status does not mean that the finished supplement is safe and effective for the intended purpose
Koochekpour, S., Majumdar, S., Azabdaftari, G., Attwood, K., Scioneaux, R., Subramani, D
V., Roychoudhury, S., & Kolesarova, A
US$ 23.45
US$ 29.84
US$ 27.54
US$ 27.02
